Another study showed that growing placenta MSCs on a 3D fluidized bioreactor and treating them with hepatoma-derived C3A significantly improved ALB, urea secretion, and increased CYP1A2 and CYP3A4 that indicated significant differentiation of SCs into hepatocytes [4]. The gene discussed is CYP3A4; the disease is hepatocellular carcinoma.